Ocugen, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ocugen, Inc and other ETFs, options, and stocks.

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN.

CEO

Shankar Musunuri

CEOShankar Musunuri

Employees

Employees95

Headquarters

Malvern, Pennsylvania

HeadquartersMalvern, Pennsylvania

Founded

2013

Founded2013

Employees

Employees95

OCGN Key Statistics

Market cap

441.91M

Market cap441.91M

Price-Earnings ratio

-6.69

Price-Earnings ratio-6.69

Dividend yield

—

Dividend yield—

Average volume

3.59M

Average volume3.59M

High today

$1.49

High today$1.49

Low today

$1.28

Low today$1.28

Open price

$1.42

Open price$1.42

Volume

13.13M

Volume13.13M

52 Week high

$1.49

52 Week high$1.49

52 Week low

$0.515

52 Week low$0.515

OCGN News

TipRanks 8h

Ocugen Faces Merger Termination with Carisma Therapeutics

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Benzinga 3d

Ocugen Shares Are Trading Higher Monday: What's Going On?

Zinger Key Points Ocugen signs a licensing agreement granting Kwangdong exclusive Korean rights to OCU400. The agreement includes up to $7.5 million in upfront...

People also own

Based on the portfolios of people who own OCGN. This list is generated using Robinhood data, and it’s not a recommendation.